Hemostatic abnormalities in patients with ehlers-danlos syndrome.

CONCLUSIONS: Our results show that nearly half of patients with EDS have abnormal BSS, that in 90% of cases appears at least in part justified by platelet function abnormalities. Abnormalities of primary hemostasis may contribute to the risk of bleeding in patients with EDS. This article is protected by copyright. All rights reserved. PMID: 30312027 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30312027?dopt=Abstract

Source: Thrombosis and Haemostasis - October 12, 2018 Category: Hematology Authors: Artoni A, Bassotti A, Abbattista M, Marinelli B, Lecchi A, Gianniello F, Clerici M, Bucciarelli P, La Marca S, Peyvandi F, Martinelli I Tags: J Thromb Haemost Source Type: research